New research reveals three crucial blood markers that could predict heart disease risk in women decades in advance, revolutionizing prevention strategies.
Physicians at Mass General Brigham, Beth Israel, and Cambridge Health Alliance are driven by a conviction that their employers are putting business considerations over medical ones.
The clinical site is led by Brigham and Women’s Hospital researchers Ann Woolley, M.D., and David Leaf, M.D. The double-blind, placebo-controlled trial will examine outcomes for hospitalized ...